Keenova Therapeutics plc Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Keenova Therapeutics plc payments for repurchase of common stock for the quarter ending 2026-06-30 was $0.00.
- Keenova Therapeutics plc payments for repurchase of common stock for the quarter ending 2026-03-31 was $1.90M, a 0.00% change year-over-year.
- Keenova Therapeutics plc payments for repurchase of common stock for the quarter ending 2025-09-26 was $0.00.
- Keenova Therapeutics plc payments for repurchase of common stock for the quarter ending 2025-06-27 was $0.00.
- Keenova Therapeutics plc payments for repurchase of common stock for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Keenova Therapeutics plc payments for repurchase of common stock for fiscal 2020 was $400.00K, a 84.62% decline from fiscal 2019.
- Keenova Therapeutics plc payments for repurchase of common stock for fiscal 2019 was $2.60M, a 95.48% decline from fiscal 2018.
- Keenova Therapeutics plc payments for repurchase of common stock for fiscal 2018 was $57.50M, a 91.18% decline from fiscal 2017.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | |
| 2026-03-31 | $1.90M 10-Q · filed 2026-05-12 | |
| 2025-09-26 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | |
| 2025-06-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | |
| 2025-03-28 | $1.90M 10-Q · filed 2026-05-12 | |
| 2024-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | |
| 2024-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | |
| 2024-03-29 | $0.00 10-Q · filed 2025-05-12 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $0.00 10-K · filed 2022-03-15 |
| 2021-09-24 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | |
| 2020-12-25 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $400.00K 10-K · filed 2022-03-15 |
| 2020-09-25 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $500.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-26 | $300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $400.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-27 | $0.00 10-Q · filed 2020-05-06 | $2.10M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-27 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.60M 10-K · filed 2022-03-15 |
| 2019-09-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | $2.60M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-28 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $3.20M derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-29 | $500.00K 10-Q · filed 2020-05-06 | $11.40M derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-28 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-10 | $57.50M 10-K · filed 2021-03-10 |
| 2018-09-28 | $600.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $271.40M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-29 | $10.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $327.70M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-30 | $46.60M 10-Q · filed 2019-05-07 | $418.70M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-29 | $214.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $651.70M 10-K · filed 2020-02-26 |
| 2017-09-29 | $56.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $596.50M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $101.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $590.50M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $279.60M 10-Q · filed 2018-05-08 | $589.70M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-30 | $158.80M 10-K · filed 2019-02-26 | $536.30M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-09-30 | $50.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $652.90M 10-K · filed 2019-02-26 |
| 2016-06-24 | $100.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $678.80M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-03-25 | $226.20M 10-Q · filed 2017-05-08 | $581.50M derived: sum of 4 quarters · filed 2019-02-26 |
| 2015-12-25 | $275.40M 10-K · filed 2019-02-26 | $357.00M derived: sum of 4 quarters · filed 2019-02-26 |
| 2015-09-25 | $76.80M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $92.20M 10-K · filed 2018-02-27 |
| 2015-06-26 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-02 | $31.00M derived: sum of 4 quarters · filed 2016-11-29 |
| 2015-03-27 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-03 | $28.00M derived: sum of 4 quarters · filed 2016-11-29 |
| 2014-12-26 | $10.60M 10-Q · filed 2016-02-02 | $27.20M derived: sum of 4 quarters · filed 2016-11-29 |
| 2014-09-26 | $15.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-29 | $17.50M 10-K · filed 2016-11-29 |
| 2014-06-27 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-04 | $1.90M derived: sum of 4 quarters · filed 2015-11-24 |
| 2014-03-28 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-05 | $1.80M derived: sum of 4 quarters · filed 2015-11-24 |
| 2013-12-27 | $900.00K 10-Q · filed 2015-02-03 | $900.00K derived: sum of 4 quarters · filed 2015-11-24 |
| 2013-09-27 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-24 | $0.00 10-K · filed 2015-11-24 |
| 2013-06-28 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-07 | |
| 2013-03-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-08 | |
| 2012-12-28 | $0.00 10-Q · filed 2014-02-07 | |
| 2012-09-28 | $0.00 8-K · filed 2015-04-03 |